Supramolecular assemblies based on complexes of nonionic amphiphilic cyclodextrins and a meso-tetra(4-sulfonatophenyl)porphine tributyltin(IV) derivative: potential nanotherapeutics against melanoma.

Amphiphilic cyclodextrin (ACyD) provides water-soluble and adaptable nanovectors by modulating the balance between the hydrophobic and hydrophilic chains at both CyD sides. This work aimed to design nanoassemblies based on nonionic and hydrophilic ACyD (SC6OH) for the delivery of a poor-water-soluble organotin(IV)-porphyrin derivative [(Bu3Sn)4TPPS] to melanoma cancer cells. To characterize the porphyrin derivatives under simulated physiological conditions, a speciation was performed using complementary techniques. In aqueous solution (≤ 20 μM), (Bu3Sn)4TPPS primarily exists as a monomer (2 in Figure 1), as suggested by the low static anisotropy (ρ ≈ 0.02) with a negligible formation of porphyrin supramolecular aggregates. MALDI-TOF spectra indicate the presence of moieties (i.e., [(Bu3Sn)3TPPS](-)) that are derivatives of the monomeric species. Spectrofluorimetry coupled with potentiometric measurements primarily assesses the presence of the hydrolytic [(Bu3Sn)4TPPS (OH)4](4-) species under physiological conditions. Nanoassemblies of (Bu3Sn)4TPPS/SC6OH were prepared by dispersion of organic films in PBS at pH 7.4 and were investigated using a combination of spectroscopic and morphological techniques. The UV-vis and emission fluorescence spectra of the (Bu3Sn)4TPPS/SC6OH reveal shifts in the peculiar bands of the organotin(IV)-porphyrin derivative due to its interaction with the ACyD supramolecular assemblies in aqueous solution. The mean size was within the range of 100-120 nm. The ξ-potential was negative (-16 mV) for the (Bu3Sn)4TPPS/SC6OH nanoassemblies, with an entrapment efficiency of approximately 67%. The intracellular delivery, cytotoxicity, nuclear morphology and cell growth kinetics were evaluated via fluorescence microscopy on A375 human melanoma cells. The delivery of (Bu3Sn)4TPPS by ACyD with respect to free (Bu3Sn)4TPPS increases the internalization efficiency and cytotoxicity to induce apoptotic cell death and, at lower concentrations, changes the cellular morphology and prevents cell proliferation.

[1]  T. Parisi,et al.  Supramolecular hybrid assemblies based on gold nanoparticles, amphiphilic cyclodextrin and porphyrins with combined phototherapeutic action , 2013 .

[2]  V. Villari,et al.  Nanostructures of cationic amphiphilic cyclodextrin complexes with DNA. , 2013, Biomacromolecules.

[3]  J. Voskuhl,et al.  A soft supramolecular carrier with enhanced singlet oxygen photosensitizing properties , 2013 .

[4]  J. Dowell,et al.  Vemurafenib: targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies. , 2012, Drugs.

[5]  R. Ambrus,et al.  Betulin Complex in γ-Cyclodextrin Derivatives: Properties and Antineoplasic Activities in In Vitro and In Vivo Tumor Models , 2012, International journal of molecular sciences.

[6]  V. del Marmol,et al.  Melanoma incidence and mortality in Europe: new estimates, persistent disparities , 2012, The British journal of dermatology.

[7]  S. Moffatt-Bruce The immunobiology of photodynamic therapy: the potential for therapeutic intervention in lung cancer. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  A. El-Sherif Solution Coordination Chemistry of Organotin(IV) Cations with Bio-relevant Ligands , 2012, Journal of Solution Chemistry.

[9]  J. Dimmock,et al.  Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Melody J Eide,et al.  Update on the current state of melanoma incidence. , 2012, Dermatologic clinics.

[11]  R. Dummer,et al.  Sorafenib in melanoma , 2012, Expert opinion on investigational drugs.

[12]  T. Parisi,et al.  A cyclodextrin-based nanoassembly with bimodal photodynamic action. , 2012, Chemistry.

[13]  C. Verschraegen The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma , 2012, Cancer management and research.

[14]  F. Ungaro,et al.  Nanocapsules based on linear and Y-shaped 3-miktoarm star-block PEO-PCL copolymers as sustained delivery system for hydrophilic molecules. , 2011, Biomacromolecules.

[15]  G. Giammona,et al.  Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2 , 2011, International journal of nanomedicine.

[16]  J. M. Benito,et al.  Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery. , 2011, Biomaterials.

[17]  Zhaoyong Wu,et al.  Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity , 2011, International journal of nanomedicine.

[18]  V. Villari,et al.  Effective cell uptake of nanoassemblies of a fluorescent amphiphilic cyclodextrin and an anionic porphyrin. , 2011, Chemical communications.

[19]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[20]  A. Mazzaglia Photodynamic Tumor Therapy with Cyclodextrin Nanoassemblies , 2011 .

[21]  A. Scala,et al.  Synthesis and anti HSV-1 evaluation of novel indole-3,4-diones , 2011 .

[22]  F. Zito,et al.  Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine] manganese(III)chloride. , 2011, International journal of oncology.

[23]  G. Kociok‐Köhn,et al.  Diorganotin-based coordination polymers derived from sulfonate/phosphonate/phosphonocarboxylate ligands. , 2011, Inorganic chemistry.

[24]  G. Giammona,et al.  Curcumin Entrapped Into Lipid Nanosystems Inhibits Neuroblastoma Cancer Cell Growth and Activates Hsp70 Protein , 2010 .

[25]  Yibin Kang,et al.  The Multifaceted Role of MTDH/AEG-1 in Cancer Progression , 2009, Clinical Cancer Research.

[26]  W. Gallagher,et al.  Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.

[27]  G. Jori,et al.  Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity. , 2009, Biomacromolecules.

[28]  A. Eggermont,et al.  LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951). , 2009, European journal of cancer.

[29]  G. Ingo,et al.  Supramolecular Colloidal Systems of Gold Nanoparticles/Amphiphilic Cyclodextrin: a FE-SEM and XPS Investigation of Nanostructures Assembled onto Solid Surface , 2009 .

[30]  Shiladitya Sengupta,et al.  Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy , 2009, Proceedings of the National Academy of Sciences.

[31]  M. A. Costa,et al.  Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells. , 2009, Oncology reports.

[32]  A. Bosserhoff,et al.  Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma , 2009, The Journal of Experimental Medicine.

[33]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.

[34]  E. Bilensoy,et al.  Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel. , 2008, Journal of pharmaceutical sciences.

[35]  A. Zizzi,et al.  Involvement of E‐cadherin, β‐catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma , 2007, The British journal of dermatology.

[36]  G. Fields,et al.  Targeted drug delivery utilizing protein-like molecular architecture. , 2007, Journal of the American Chemical Society.

[37]  S. Spadaro,et al.  Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies , 2006 .

[38]  M. A. Costa,et al.  Diorganotin(IV) and triorganotin(IV) complexes of meso-tetra(4-sulfonatophenyl)porphine induce apoptosis in A375 human melanoma cells. , 2006, Cancer letters.

[39]  N. Micali,et al.  Unusual optical properties of porphyrin fractal J-aggregates. , 2005, Chemical communications.

[40]  I. Vural,et al.  Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[41]  A. Mazzaglia,et al.  Structural properties of nonionic cyclodextrin colloids in water. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[42]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[43]  A. Oseroff,et al.  Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.

[44]  J. Jacquier,et al.  Molecular recognition of polymers by cyclodextrin vesicles. , 2003, Angewandte Chemie.

[45]  Cyril Aymonier,et al.  Hybrids of silver nanoparticles with amphiphilic hyperbranched macromolecules exhibiting antimicrobial properties. , 2002, Chemical communications.

[46]  M. Castriciano,et al.  Aggregation of meso-tetrakis(4-sulfonatophenyl)porphyrin on polyethyleneimine in aqueous solutions and on a glass surface , 2002 .

[47]  C. Dang,et al.  Translocations involving c-myc and c-myc function , 2001, Oncogene.

[48]  A. Mazzaglia,et al.  Novel Amphiphilic Cyclodextrins: Graft‐Synthesis of Heptakis(6‐alkylthio‐6‐deoxy)‐β‐cyclodextrin 2‐Oligo(ethylene glycol) Conjugates and Their ω‐Halo Derivatives , 2001 .

[49]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[50]  Vitalini,et al.  Effect of combined changes in delayed extraction time and potential gradient on the mass resolution and ion discrimination in the analysis of polydisperse polymers and polymer blends by delayed extraction matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 1999, Rapid communications in mass spectrometry : RCM.

[51]  L. Pellerito,et al.  Organometallic complexes with biological molecules. IX. Diorgano- and triorgano-tin(IV)[meso-tetra (4-sulfonatophenyl)porphinate] derivatives: solid-state and solution-phase structural aspects and in vivo effects , 1997 .

[52]  Martin Kussmann,et al.  Matrix‐assisted Laser Desorption/Ionization Mass Spectrometry Sample Preparation Techniques Designed for Various Peptide and Protein Analytes , 1997 .

[53]  P. Gans,et al.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. , 1996, Talanta.

[54]  S. Aaronson,et al.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. , 1973, Journal of the National Cancer Institute.

[55]  G. Giammona,et al.  Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. , 2010, Nanomedicine.

[56]  V. Villari,et al.  The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. , 2009, Biomaterials.

[57]  N. Safari,et al.  Complexation of 5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin with Zinc(II) Ions in Aqueous Solution , 2008 .

[58]  Johan Moan,et al.  A new method for photodynamic therapy of melanotic melanoma -- effects of depigmentation with violet light photodynamic therapy. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[59]  L. Pellerito,et al.  Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects , 2002 .

[60]  S. Sammartano,et al.  Hydrolysis and chemical speciation of (C2H5)2Sn2+, (C2H5)3Sn+ and (C3H7)3Sn+ in aqueous media simulating the major composition of natural waters , 2002 .

[61]  R. Steiner,et al.  Basic reaction mechanisms of hydrophilic and lipophilic photosensitisers in photodynamic tumour treatment , 1998 .